CONMED CORPORATION Letters of Credit Outstanding, Amount
CONMED CORPORATION (CNMD) had Letters of Credit Outstanding, Amount of $4.80 million as of 2016-09-30, per its 10-Q filed 2016-10-28.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2016-10-28
- 2016-09-30: Letters of Credit Outstanding, Amount $4.80M.
- 2016-06-30: Letters of Credit Outstanding, Amount $4.80M.
- 2016-03-31: Letters of Credit Outstanding, Amount $5.10M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2016-09-30 | $4.80M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $4.80M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $5.10M 10-Q · filed 2016-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |